Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to help smokers with mental illness kick the habit

NCT ID NCT06926153

Disease control Sponsor: GCS-CCOMS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 21, 2026 · Updated 1 time

Summary

This study tests a program called Tabapsy to help people with mental health conditions who smoke. The program includes information meetings, assessments, and workshops on quitting. Researchers will compare it to usual care in 6,500 adults from psychiatric clinics, measuring if they can stop smoking for at least 7 days after 3 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention (smoking cessation program with workshops and nicotine replacement guidance)
What this could lead to
If successful, this program could help many people with mental health conditions quit smoking, potentially reducing their risk of early death from tobacco-related diseases.
What could go wrong
This is a behavioral intervention, so results depend on individual motivation and support. The study is still recruiting, and long-term success beyond 3 months is not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 6,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Regular smokers (at least one cigarette per day) * Followed in psychiatric ambulatory care at one of the participating sectors' CMPs * Adults (18 years or older) * Covered by the statuary health insurance * Who gave their informed consent to participate to the study Exclusion Criteria: * Users under guardianship or legal protection, * Psychological state incompatible with completing the questionnaire, * Persons with no command or understanding of the French language

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Tobacco addiction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nicotine dependence Smoking Reduction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Tobacco addiction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Barthelemy Durand public health establishment (91G05)

    RECRUITING

    Étampes, 91150, France

  • Flanders public mental health establishment (59G05/06)

    COMPLETED

    Bailleul, 59270, France

  • Hospital Care Center of Nanterre (92G10)

    COMPLETED

    Nanterre, 92014, France

  • Hospital Center of Rouffach (68G02/03)

    COMPLETED

    Rouffach, 68250, France

  • Hospital Center of Rouffach (68G08/09)

    COMPLETED

    Rouffach, 68250, France

  • Hospital Center of Rouffach (Pôle LTD - 68G04/05)

    COMPLETED

    Rouffach, 68250, France

  • Hospitals of Paris Est Val de Marne (94G01)

    COMPLETED

    Saint-Maurice, 94410, France

  • Hospitals of Paris Est Val de Marne (94G16)

    COMPLETED

    Saint-Maurice, 94410, France

  • Hospitals of Paris Est Val de Marne (Paris 11)

    COMPLETED

    Saint-Maurice, 94410, France

  • Hospitals of Paris Est Val de Marne (Paris 12)

    COMPLETED

    Saint-Maurice, 94410, France

  • Hospitals of Paris Est Val de Marne (Paris Centre)

    COMPLETED

    Saint-Maurice, 94410, France

  • Psychotherapeutic center of Nancy (54G02-06)

    COMPLETED

    Laxou, 54520, France

  • Public mental health establishment of Guadeloupe (96G01)

    RECRUITING

    Saint-Claude, 97122, Guadeloupe

  • Public mental health establishment of Guadeloupe (96G06)

    RECRUITING

    Saint-Claude, 97122, Guadeloupe

  • Public mental health establishment of Lille Metropole (59G16-G17)

    COMPLETED

    Armentières, 59280, France

  • Public mental health establishment of Lille Metropole (59G21)

    COMPLETED

    Armentières, 59280, France

  • Public mental health establishment of Reunion Island (Pôle Nord)

    COMPLETED

    Saint-Paul, 97460, Reunion

  • Public mental health establishment of Val de Lys Artois (62G09)

    COMPLETED

    Saint-Venant, 62350, France

  • Public mental health establishment of Val de Lys Artois (62G12)

    COMPLETED

    Saint-Venant, 62350, France

  • Public mental health establishment of Val de Lys Artois (Pôle du Ternois)

    COMPLETED

    Saint-Venant, 62350, France

  • University Hospital Center of Lille (59G08)

    WITHDRAWN

    Lille, 59000, France

  • University Hospital Group Paris Neurosciences & Psychiatry (75G04)

    COMPLETED

    Paris, 75014, France